NO179206C - Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-amino-4-morfolino-6-propyl-1,3,5-triaziner - Google Patents
Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-amino-4-morfolino-6-propyl-1,3,5-triazinerInfo
- Publication number
- NO179206C NO179206C NO893279A NO893279A NO179206C NO 179206 C NO179206 C NO 179206C NO 893279 A NO893279 A NO 893279A NO 893279 A NO893279 A NO 893279A NO 179206 C NO179206 C NO 179206C
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- triazines
- morpholino
- propyl
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
- C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
- C07D251/18—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/08—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Ophthalmology & Optometry (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB888819493A GB8819493D0 (en) | 1988-08-16 | 1988-08-16 | 2-amino-4-morpholino-6-propyl-1 3 5-triazines |
Publications (4)
Publication Number | Publication Date |
---|---|
NO893279D0 NO893279D0 (no) | 1989-08-15 |
NO893279L NO893279L (no) | 1990-02-19 |
NO179206B NO179206B (no) | 1996-05-20 |
NO179206C true NO179206C (no) | 1996-08-28 |
Family
ID=10642235
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO893279A NO179206C (no) | 1988-08-16 | 1989-08-15 | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-amino-4-morfolino-6-propyl-1,3,5-triaziner |
Country Status (28)
Country | Link |
---|---|
US (1) | US4956367A (no) |
EP (1) | EP0356413B1 (no) |
JP (1) | JPH02108675A (no) |
KR (1) | KR0136108B1 (no) |
AT (1) | ATE72241T1 (no) |
AU (1) | AU614247B2 (no) |
CA (1) | CA1317944C (no) |
CY (1) | CY1709A (no) |
DE (1) | DE68900794D1 (no) |
DK (1) | DK171698B1 (no) |
ES (1) | ES2038849T3 (no) |
FI (1) | FI102065B1 (no) |
GB (1) | GB8819493D0 (no) |
GR (1) | GR3004267T3 (no) |
HK (1) | HK95693A (no) |
HU (1) | HUT58087A (no) |
IE (1) | IE61205B1 (no) |
IL (1) | IL91243A (no) |
LT (1) | LT3601B (no) |
MY (1) | MY105008A (no) |
NO (1) | NO179206C (no) |
NZ (1) | NZ230290A (no) |
PL (2) | PL161591B1 (no) |
PT (1) | PT91438B (no) |
RU (3) | RU1806142C (no) |
SG (1) | SG27893G (no) |
UA (1) | UA11064A (no) |
ZA (1) | ZA896222B (no) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9024617D0 (en) * | 1989-12-05 | 1991-01-02 | Ici Plc | Heterocyclic compounds |
GB9008818D0 (en) * | 1990-04-19 | 1990-06-13 | Ici Plc | Amine derivatives |
IT1240690B (it) * | 1990-04-30 | 1993-12-17 | Ciba Geigy Ag | Composti piperdin-triazinici atti all'impiego come stabilizzanti per materiali organici |
GB9116039D0 (en) * | 1991-07-25 | 1991-09-11 | Ucb Sa | Substituted cyclopropylamino-1,3,5-triazines |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3549755A (en) * | 1968-03-27 | 1970-12-22 | Shell Oil Co | Use of 2-trichloromethyl-4-morpholinoor piperazino-6-substituted-s-triazines for inducing depressant effects in animals |
JPS4969688A (no) * | 1972-11-02 | 1974-07-05 | ||
FR2262512A1 (en) * | 1974-03-01 | 1975-09-26 | Synthelabo | 2,4,6-Tri-substd. -1,3,5-triazines - with analgesic and psychotropic activity |
-
1988
- 1988-08-16 GB GB888819493A patent/GB8819493D0/en active Pending
-
1989
- 1989-07-28 EP EP89870120A patent/EP0356413B1/fr not_active Expired - Lifetime
- 1989-07-28 AT AT89870120T patent/ATE72241T1/de not_active IP Right Cessation
- 1989-07-28 ES ES198989870120T patent/ES2038849T3/es not_active Expired - Lifetime
- 1989-07-28 DE DE8989870120T patent/DE68900794D1/de not_active Expired - Lifetime
- 1989-08-07 FI FI893714A patent/FI102065B1/fi not_active IP Right Cessation
- 1989-08-08 IL IL9124389A patent/IL91243A/en not_active IP Right Cessation
- 1989-08-08 US US07/390,878 patent/US4956367A/en not_active Expired - Fee Related
- 1989-08-09 CA CA000607834A patent/CA1317944C/en not_active Expired - Fee Related
- 1989-08-09 MY MYPI89001088A patent/MY105008A/en unknown
- 1989-08-11 PL PL89283603A patent/PL161591B1/pl unknown
- 1989-08-11 PL PL1989281021A patent/PL161161B1/pl unknown
- 1989-08-11 PT PT91438A patent/PT91438B/pt not_active IP Right Cessation
- 1989-08-14 NZ NZ230290A patent/NZ230290A/xx unknown
- 1989-08-14 DK DK398189A patent/DK171698B1/da active
- 1989-08-15 ZA ZA896222A patent/ZA896222B/xx unknown
- 1989-08-15 HU HU894192A patent/HUT58087A/hu unknown
- 1989-08-15 NO NO893279A patent/NO179206C/no unknown
- 1989-08-15 RU SU894614758A patent/RU1806142C/ru active
- 1989-08-15 AU AU39917/89A patent/AU614247B2/en not_active Ceased
- 1989-08-15 JP JP1210547A patent/JPH02108675A/ja active Pending
- 1989-08-15 IE IE261989A patent/IE61205B1/en not_active IP Right Cessation
- 1989-08-16 KR KR1019890011696A patent/KR0136108B1/ko not_active IP Right Cessation
- 1989-12-21 UA UA4742645A patent/UA11064A/uk unknown
- 1989-12-21 RU SU894742645A patent/RU1822403C/ru active
-
1990
- 1990-08-20 RU SU904830673A patent/RU1838312C/ru active
-
1992
- 1992-04-02 GR GR920400622T patent/GR3004267T3/el unknown
-
1993
- 1993-03-16 SG SG278/93A patent/SG27893G/en unknown
- 1993-08-03 LT LTIP829A patent/LT3601B/lt not_active IP Right Cessation
- 1993-09-16 HK HK956/93A patent/HK95693A/xx not_active IP Right Cessation
-
1994
- 1994-01-14 CY CY170994A patent/CY1709A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO912429D0 (no) | Fremgangsmaate for fremstilling av aralifatiske n-substituerte aminoalkanfosfinsyrer. | |
ATE188965T1 (de) | Neue pyrazincarboxamidderivate, ihre herstellung und ihre verwendung in arzneimitteln | |
NO902800L (no) | Fremgangsmaate for fremstilling av 11beta-aryl-4-oestrener. | |
FR2689127B1 (fr) | Nouvelles 3', 5' -ditertbutyl-4'-hydroxy flavones, leur procede de preparation et les compositions pharmaceutiques les renfermant. | |
NO302523B1 (no) | Heterosykliske forbindelser, farmasöytiske preparater som omfatter dem, og anvendelse av forbindelsene for fremstilling av medikamenter | |
ATE75942T1 (de) | Verwendung von 2-amino-4-morpholino-6-propyl1,3,5-triazin zur herstellung eines medikaments zur behandlung kognitiver und mentaler erkrankungen. | |
IL83141A (en) | Solutions of oxazophosphorins having improved stability and their preparation | |
NO179206C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-amino-4-morfolino-6-propyl-1,3,5-triaziner | |
ES2032501T3 (es) | Un procedimiento de preparacion de derivados de urileno-2,4,6-triamino-3-oxido. | |
GR3017916T3 (en) | 3,4-Disubstituted phenyl-heterocycles and their use. | |
HU896775D0 (en) | Fungicid compositions comprising sulfurous oximethers as active ingredient and process for preparation thereof | |
IL90043A0 (en) | Sulfonanilides,their preparation and pharmaceutical compositions containing them | |
DE68922596D1 (de) | 3-(3-Ethyl-1,2,4-oxadiazol-5-yl)-1-azabicycloheptan, Verfahren zu seiner Herstellung und dieses enthaltende pharmazeutische Zubereitungen. | |
HU905030D0 (en) | Process for producing new 1,3-oxazines and pharmaceutical preparatives containing these compounds | |
ATE134135T1 (de) | Ein imidazobenzodiazepin zur behandlung von schlafstörungen | |
TH23729A (th) | พิร์โรลิลเททระไฮโดรเบนโซควินอกแซลีนไดโอน การเตรียมและการใช้สารเหล่านั้น |